Tacrolimus
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00864 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 48 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | seborrheic dermatitis | KG + DL |
| 2 | parapsoriasis | KG + DL |
| 3 | dermatitis | KG + DL |
| 4 | acute lichenoid pityriasis | KG + DL |
| 5 | acrodermatitis chronica atrophicans | KG + DL |
| 6 | rheumatoid arthritis | KG + DL |
| 7 | acne keloid | KG + DL |
| 8 | psoriasis | KG + DL |
| 9 | neonatal dermatomyositis | KG + DL |
| 10 | exanthem (disease) | KG + DL |
| 11 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 12 | amyopathic dermatomyositis | KG + DL |
| 13 | bronchitis | KG + DL |
| 14 | pityriasis lichenoides | KG + DL |
| 15 | hydroa vacciniforme, familial | KG + DL |
| 16 | brachydactyly-syndactyly syndrome | KG + DL |
| 17 | pustulosis palmaris et plantaris | KG + DL |
| 18 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 19 | Crohn’s colitis | KG + DL |
| 20 | psoriasis 14, pustular | KG + DL |
| 21 | pemphigus | KG + DL |
| 22 | 2-hydroxyethyl methacrylate sensitization | KG + DL |
| 23 | polyp of vocal cord | KG + DL |
| 24 | epulis | KG + DL |
| 25 | polyp of middle ear | KG + DL |
| 26 | fibroepithelial polyp | KG + DL |
| 27 | polyp of frontal sinus | KG + DL |
| 28 | polyp of ureter | KG + DL |
| 29 | polyp of vulva | KG + DL |
| 30 | neoplastic polyp | KG + DL |
| 31 | polyp of external auditory canal | KG + DL |
| 32 | uterine polyp | KG + DL |
| 33 | pemphigus vegetans | KG + DL |
| 34 | inflammatory bowel disease | KG + DL |
| 35 | lipoid nephrosis | KG + DL |
| 36 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 37 | candidiasis, familial | KG + DL |
| 38 | Crohn disease of the esophagus | KG + DL |
| 39 | seborrheic keratosis | KG + DL |
| 40 | persistent polyclonal B-cell lymphocytosis | KG + DL |
| 41 | granulomatous disease with defect in neutrophil chemotaxis | KG + DL |
| 42 | anus disease | KG + DL |
| 43 | folliculotropic mycosis fungoides | KG + DL |
| 44 | vulvar inverted follicular keratosis | KG + DL |
| 45 | functional neutrophil defect | KG + DL |
| 46 | granulomatous disease, chronic, autosomal recessive, 5 | KG + DL |
| 47 | BENTA disease | KG + DL |
| 48 | severe combined immunodeficiency due to CARD11 deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.